Upregulation of human mammaglobin reduces migration and invasion of breast cancer cells

Cancer Investigation

Volumn 32, Issue 1, 2014, Pages 22-29

  Koh, Eun Ha ^b   Cho, Young Woo ^a   Mun, Yun Ja ^a   Ryu, Ji Hyeon ^a   Kim, Eun Jin ^a   Choi, Dae Seob ^c   Maeng, Kook Young ^b   Han, Jaehee ^a   Kang, Dawon ^a  

^a Departments of Physiology   (South Korea)

^b Departments of Dermatology   (South Korea)

^c Gyeongsang National University   (South Korea)

Author keywords

Breast cancer; Gene expression; Invasion and metastasis

Indexed keywords

CHLORMETHINE; CYTOKERATIN 14; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MAMMAGLOBIN; MESSENGER RNA; TUMOR MARKER; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

EID: 84891553282     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357907.2013.861473     Document Type: Article

References (30)

1. Keen JC, Davidson NE.The biology of breast carcinoma. Cancer 2003;97(3 Suppl):825-833.
2. Chung C, Christianson M. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers:Asystemic reviewof current development, evidence, and recommendation. J Oncol Pharm Pract 2013.
3. Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 1996;56(4):860-865.
4. Carter D, Douglass JF, Cornellison CD, Retter MW, Johnson JC, Bennington AA, Fleming TP, Reed SG, Houghton RL, Diamond DL, Vedvick TS. Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochemistry 2002;41(21):6714-6722.
5. Span PN, Waanders E, Manders P, Heuvel JJ, Foekens JA, Watson MA, Beex LV, Sweep FC. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J Clin Oncol 2004;22(4):691-698.
6. Zuo L, Li L, Wang Q, Fleming TP, You S.Mammaglobin as a potential molecular target for breast cancer drug delivery. Cancer Cell Int 2009;9:8.
7. Lee GW, Kim JY, Koh EH, Kang D, Choi DS, Maeng KY, Lee JS. Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer. Genet Mol Res 2012;11(4):4034-4042.
8. Mykhaylyk O, Zelphati O, Hammerschmid E, Anton M, Rosenecker J, Plank C. Recent advances in magnetofection and its potential to deliver siRNAs in vitro. Methods Mol Biol 2009;487:111-146.
9. Lee GW, Park HS, Kim EJ, Cho YW, Kim GT, Mun YJ, Choi EJ, Lee JS, Han J, Kang D. Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+ channel. Acta Physiol (Oxf) 2012;204(4):513-524.
10. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T,Wang P, Gazdar AF, Minna JD, Pollack JR. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 2009;4(7):e6146.
11. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008;68(4):989-997.
12. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009;28(1-2):15-33.
13. Li G, Zhang J, Jin K, He K,Wang H, Lu H, Teng L. Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients. Biomark Med 2011;5(2):249-260.
14. Reinholz MM, Kitzmann KA, Tenner K, Hillman D, Dueck AC, Hobday TJ, Northfelt DW, Moreno-Aspitia A, Roy V, LaPlant B, Allred JB, Stella PJ, Lingle WL, Perez EA. Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437. Clin Cancer Res 2011;17(22):7183-7193.
15. Raica M, Cimpean AM, Meche A, Alexa A, Suciu C, Muresan A. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph nodemetastasis. Rom J Morphol Embryol 2009;50(3):341-347.
16. Sasaki E, Tsunoda N, Hatanaka Y, Mori N, Iwata H, Yatabe Y. Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers. Mod Pathol 2007;20(2):208-214.
17. Liu Y, Ma L, Liu X,Wang L. Expression of human mammaglobin as amarker of bonemarrowmicrometastasis in breast cancer. Exp Ther Med 2012;3(3):550-554.
18. Sjodin A, Guo D, Sorhaug S, Bjermer L, Henriksson R, Hedman H. Dysregulated secretoglobin expression in human lung cancers. Lung Cancer 2003;41(1):49-56.
19. Tassi RA, Bignotti E, Rossi E, Falchetti M, Donzelli C, Calza S, Ravaggi A, Bandiera E, Pecorelli S, Santin AD. Overexpression of mammaglobin B in epithelial ovarian carcinomas. Gynecol Oncol 2007;105(3):578-585.
20. Tassi RA, Bignotti E, Falchetti M, Calza S, Ravaggi A, Rossi E, Martinelli F, Bandiera E, Pecorelli S, Santin AD. Mammaglobin B expression in human endometrial cancer. Int J Gynecol Cancer 2008;18(5):1090-1096.
21. Zafrakas M, Petschke B, Donner A, Fritzsche F, Kristiansen G, Knuchel R, Dahl E. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their coexpression in gynecologic malignancies. BMC Cancer 2006;6:88.
22. Reyes C, Gomez-Fernandez C, Nadji M. Metaplastic and medullary mammary carcinomas do not express mammaglobin. Am J Clin Pathol 2012;137(5):747-752.
23. Koga T, Horio Y, Mitsudomi T, Takahashi T, Yatabe Y. Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data. J Mol Diagn 2004;6(2):90-95.
24. Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 2001;17(6):509-519.
25. Szallasi Z. Genetic network analysis in light of massively parallel biological data acquisition. Pac Symp Biocomput 1999:5-16.
26. Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003;4(9):117.
27. Cui H, Zhang W, Hu W, Liu K, Wang T, Ma N, Liu X, Liu Y, Jiang Y. Recombinant mammaglobin A adenovirus-infected dendritic cells induce mammaglobin A-specific CD8 +cytotoxic T lymphocytes against breast cancer cells in vitro. PLoS One 2013;8(5):e63055.
28. Guan XF, Hamedani MK, Adeyinka A, Walker C, Kemp A, Murphy LC, Watson PH, Leygue E. Relationship between mammaglobin expression and estrogen receptor status in breast tumors. Endocrine 2003;21(3):245-50.
29. Nunez-Villar MJ, Martinez-Arribas F, Pollan M, Lucas AR, Sanchez J, Tejerina A, Schneider J. Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype. Breast Cancer Res 2003;5(3):R65-R70.
30. Roth W, HatzfeldM, Friedrich M, Thiering S,Magin TM. Keratin function and regulation in tissue homeostasis and pathogenesis. BioMol Concepts 2012;3(6):161-173.